Viewing Study NCT05909462



Ignite Creation Date: 2024-05-06 @ 7:07 PM
Last Modification Date: 2024-10-26 @ 3:01 PM
Study NCT ID: NCT05909462
Status: COMPLETED
Last Update Posted: 2023-06-18
First Post: 2023-06-01

Brief Title: Comparison of the Effects Suprascapular Nerve Block and Intra-articular Shoulder Injection
Sponsor: Hitit University
Organization: Hitit University

Study Overview

Official Title: Comparison of the Effects of Ultrasonography-guided Suprascapular Nerve Block and Intra-articular Shoulder Injection on Pain Functional Status and Range of Motion in Patients With Adhesive Capsulitis Randomized Controlled Trial
Status: COMPLETED
Status Verified Date: 2023-06
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Objectives In this study we aimed to compare the efficacy of ultrasonography-guided suprascapular nerve block and intra-articular shoulder injection treatment in terms of joint range of motion pain and functional status in patients with adhesive capsulitis AC

Patients and Methods 60 patients AC were included in our study The patients were randomized into two groups according to the sealed envelope method In the evaluation of the patients before the injection age gender body mass index BMI occupation education duration of complaint symptomatic side and dominant hand information were recorded In the first group 2 ml of 40 mg triamcinolone acetonide and 4 ml of 1 lidocaine injection were mixed with the posterior approach method into the shoulder joint under the guidance of ultrasonography USG The second group underwent suprascapular nerve block SSNB injection with 2 ml of 40 mg triamcinolone acetonide and 4 ml of 1 lidocaine under USG guidance Shoulder range of motion ROM visual analog scale VAS scores and Shoulder Pain and Disability Index SPADI scores were compared before the injection on the tenth day after the injection and at the third month after the injection

Conclusion As a result of our study although it was observed that both methods provided improvement in the treatment process the significant improvement in the SSNB group indicates that it is a more reliable treatment method in AC treatment
Detailed Description: Sixty patients AC who applied to our Orthopedics-Traumatology and Physical Medicine-Rehabilitation Outpatient Clinic were included in our study The study was approved by the Hitit University Clinical Research Ethics Committee Decision number2023-56 A well-informed written consent was obtained from all participants according to the principles of the Declaration of Helsinki Patients with an age range of 18-65 years adapting to the treatment program to be applied diagnosed with unilateral stage 2-3 AC no shoulder trauma in the last 3 months no shoulder injections no bleeding disorder no history of malignancy inflammatory disease and stroke were included in the study The patients were randomized into two groups according to the sealed envelope method In the evaluation of the patients before the injection age gender body mass index BMI occupation education duration of complaint symptomatic side and dominant hand information were recorded Injections were made to the patients by the physiatrist and anesthetist researcher under the guidance of Logiq V2 portable USG device In the first group 2 ml of 40 mg triamcinolone acetonide and 4 ml of 1 lidocaine injection were mixed with the posterior approach method into the shoulder joint under the guidance of USG The second group underwent suprascapular nerve block injection with 2 ml of 40 mg triamcinolone acetonide and 4 ml of 1 lidocaine under USG guidance In addition pendulum and ladder-finger exercises were given to both groups as a home exercise program Shoulder range of motion ROM visual analog scale VAS scores and Shoulder Pain and Disability Index SPADI scores were compared before the injection on the tenth day after the injection and at the third month after the injection

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None
Secondary IDs
Secondary ID Type Domain Link
Deniz İpek OTHER None None
Abdulrahim Dündar OTHER Hitit University None
Mehmet Yalvaç OTHER None None
Murat Doğan OTHER None None